FDA clears Dexcom G7 CGM for 15-day wear
19/05/2025
The US Food and Drug Administration has cleared the extended-wear Dexcom G7 device for adult users The Dexcom G7 continuous glucose
Keeping your diabetes kit safe and in one place.
The US Food and Drug Administration has cleared the extended-wear Dexcom G7 device for adult users The Dexcom G7 continuous glucose
The use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) in addition to insulin is increasingly being viewed as a method
Recent research has found that insufficient sleep duration and late sleep onset were associated with increased glycaemic variability in middle-aged and
Obesity must be recognized and treated as a disease. This was the central message of the 23rd European Congress of Internal
Researchers at Imperial College, London are recruiting adults with Type 1 diabetes to a study aimed at better understanding the impact
ViCentra B.V., the company behind Kaleido, the insulin patch pump and automated insulin delivery (AID) system, has announced the appointment of
